CYTRX (NASDAQ:CYTR)
1.14
+0.23 (25.27%)
| CYTRX (NASDAQ:CYTR) Delayed : |
| Previous Close |
$0.91 |
|
52 Week High |
$1.72 |
|
| Open |
$0.92 |
|
52 Week Low |
$0.24 |
| Day High |
$1.14 |
|
P/E |
N/A |
| Day Low |
$0.92 |
|
EPS |
$-0.05 |
| Volume |
7,972,568 |
|
|
|
| More CYTR Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on CYTR
-
Nov 9, 2009 09:00 AM
CytRx Corporation (CYTR) Tops Q3 EPS by 3c
-
Sep 14, 2009 09:11 AM
CytRx (CYTR) and Cephalon (CEPH) Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia
-
Sep 10, 2009 09:59 AM
Morning Movers 9/10: DVAX, DARA, GNBT, XRTX, NCS Higher; PLAB, SEH, NAV Lower
-
Sep 10, 2009 08:47 AM
CytRx (CYTR) Secures Key European Patent for Arimoclomol
-
Sep 8, 2009 10:23 AM
Morning Movers 9/8: OPXA, ITLN, CBY, GTN, HLCS, ORH, CHP Higher; OSIR, CHIP, SPPI, AIG Lower
View All Reports
StreetInsider Reports on CYTR by Category
-
Sep 9, 2009 04:29 PM
Closing Update for Wednesday, Sept. 9
-
Sep 8, 2009 04:24 PM
Closing Update: Stocks String Together 3 Straight Wins, Commodities Gain
-
Aug 24, 2009 04:18 PM
Closing Update for Monday, August 24: Markets Essentially Flat
-
Aug 12, 2009 04:22 PM
Closing Update for Wednesday, August 12: The Fed's Relative Optimism Is Catching
-
Jul 28, 2009 04:28 PM
Closing Update for Tuesday, July 28: Choppy Seas, Then Rising Tide
View All Blogs
Comments on recent CYTR articles
Comments on CYTR
No comments are currently available.
on Jun 17, 2008
at 04:59 PM cytr What a great stock specializing in cutting edge breakthroughs. I purchased the stock when it was much higher and have just purchased more for the long haul. I did the same thing with Innovative Solutions years ago and look what happened
Article: Brean Murray Initiates CytRx Corp. (CYTR) with a Buy
on Jun 12, 2008
at 10:30 AM Excellent Call I thought I was crazy. Thank you for stepping in and validating my own internal analysis of Cytrx. Great Call. I hope other Analysts/Brokers will follow suite.
Article: Brean Murray Initiates CytRx Corp. (CYTR) with a Buy